Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Respiratory tract infections are one of the leading causes of mortality worldwide urging better understanding of interactions between pathogens causing these infections and the host. Here we report that an extracellular matrix component
proline/arginine-rich end leucine-rich repeat protein
(
PRELP
) is a novel antibacterial component of innate immunity. We detected the presence of
PRELP
in human bronchoalveolar lavage fluid and showed that
PRELP
can be found in alveolar fluid, resident macrophages/monocytes, myofibroblasts, and the adventitia of blood vessels in lung tissue.
PRELP
specifically binds respiratory tract pathogens
Moraxella catarrhalis
,
Haemophilus
influenzae
, and
Streptococcus pneumoniae
, but not other bacterial pathogens tested. We focused our study on
M. catarrhalis
and found that
PRELP
binds the majority of clinical isolates of
M. catarrhalis
(
n
= 49) through interaction with the ubiquitous surface protein A2/A2H.
M. catarrhalis
usually resists complement-mediated serum killing by recruiting to its surface a complement inhibitor C4b-binding protein, which is also a ligand for
PRELP
. We found that
PRELP
competitively inhibits binding of C4b-binding protein to bacteria, which enhances membrane attack complex formation on
M. catarrhalis
and thus leads to increased serum sensitivity. Furthermore,
PRELP
enhances phagocytic killing of serum-opsonized
M. catarrhalis
by human neutrophils in vitro. Moreover,
PRELP
reduces
Moraxella
adherence to and invasion of human lung epithelial A549 cells. Taken together,
PRELP
enhances host innate immunity against
M. catarrhalis
through increasing complement-mediated attack, improving phagocytic killing activity of neutrophils, and preventing bacterial adherence to lung epithelial cells.
...
PMID:PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen
Moraxella catarrhalis
. 2814 31